Friday, October 21, 2011
Paul Hammerness, M.D., Massachusetts General Hospital, Cambridge, MA
Robert L. Doyle, M.D., Psychiatry, Harvard Medical School, Boston, MA
Gagan Joshi, M.D., Psychiatry, Massachusetts General Hospital, Boston, MA
Anna Georgiopoulos, M.D., Child and Adolescent Psychiatry, Harvard Medical School, Boston, MA
Daniel A. Geller, M.D., Psychiatry, Massachusetts General Hospital, Newton, MA
Thomas J. Spencer, M.D., Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A., Massachusetts General Hospital, Boston, MA
Ashley Chilton, B.S., Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Cambridge, MA
Stephen V. Faraone, Ph.D., Departments of Psychiatry and of Neuroscience and Physiology, State University of New York Upstate Medical University, Syracuse, NY
Joseph Biederman, M.D., Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA